(Q42505029)

1 November 2017

title

Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex (English)

1 reference

1 November 2017

0 references

Alan L Hudson

1

1 reference

1 November 2017

Maggie D Lalies

series ordinal

2

1 reference

1 November 2017

Peter Silverstone

series ordinal

3

1 reference

1 November 2017

publication date

18 April 2012

1 reference

Canadian Journal of Physiology and Pharmacology

1 November 2017

published in

1 reference

1 November 2017

volume

90

1 reference

1 November 2017

issue

6

1 reference

1 November 2017

page(s)

803-809

1 reference

Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

1 November 2017

cites work

1 reference

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice

21 January 2018

1 reference

Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism

21 January 2018

1 reference

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

21 January 2018

1 reference

Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future

21 January 2018

1 reference

Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo

21 January 2018

1 reference

Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion

21 January 2018

1 reference

Combining Antidepressants for Treatment-Resistant Depression

21 January 2018

1 reference

Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats

21 January 2018

1 reference

Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the Myths

21 January 2018

1 reference

Venlafaxine exhibits pre-clinical antidepressant activity in the resident-intruder social interaction paradigm.

21 January 2018

1 reference

Augmentation strategies in patients with refractory depression

21 January 2018

1 reference

Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat

21 January 2018

1 reference

Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression?

21 January 2018

1 reference

Combined antidepressants: clinical experience

21 January 2018

1 reference

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder

21 January 2018

1 reference

A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor

21 January 2018

1 reference

Use of bupropion in combination with serotonin reuptake inhibitors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y2012-045

1 reference

1 November 2017

1 reference